Secondly, our use of shRNA‐mediated knockdown method, although yielding reproducible proliferative phenotypes across two GBM cell lines (U87MG and U251MG), inherently provides only transient suppression of NUCB2. This evidence concerns the gene NUCB2 and glioblastoma.